Keyword: Drug


Indivior Buys US Biotech Opiant

17.11.2022 -

British drugmaker Indivior has agreed to buy Opiant, a US biotech specializing in treatments for addiction and drug overdose. Indivior will pay about $145 million upfront...

Markets & Companies

EU Energy and Supply: What Will Happen Next?

26.10.2022 -

The European Commission proposed last month an emergency intervention in Europe’s energy markets to address recent dramatic price rises as the EU faces the effects of a...


Roche Sues Pfizer to Block Herceptin Copy

24.11.2017 - In a suit filed in the state of Delaware, the Swiss-based Roche Holding is suing Pfizer to block the future marketing a biosimilar of its breast-cancer drug Herceptin in the US...

Markets & Companies

APIs: Evaluating Supply and Demand

27.09.2017 - The market for active pharmaceutical ingredients (APIs) is approximately $140 billion and is projected to reach nearly $190 billion by 2020. So what does the market show? The API...


Old Levothyrox to be Reintroduced in France

18.09.2017 - An older version of a thyroid drug made by Merck Serono is planned to be reintroduced in France after more than 9,000 of the country's three million users complained of serious...


UK and Canada Link in Antibacterial Drug Project

12.07.2017 - LifeArc, the UK medical research charity previously known as MRC Technology, is to collaborate with the government’s Defence Science and Technology Laboratory (Dstl) and Canada’s...


FDA Stops US Merck Keytruda Trials

12.07.2017 - The US Food and Drug Administration (FDA) has placed a clinical hold on three phase 3 multiple myeloma studies testing US drugmaker Merck’s Keytruda (pembrolizumab) in combination...


Journalists Unhappy with Drugmaker Communications

22.06.2017 - In unusually open criticism of a sector journalists report on widely, the digital communications platform ISEBOX has accused the international pharmaceutical industry of failing to...